Long-Term Liabilities: The sum of all non-current liabilities.
Gilead Sciences, Inc. (GILD) had Long-Term Liabilities of $24.59B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$7.92B |
|
$2.18B |
|
$1.62B |
|
$6.30B |
|
$5.94B |
|
$1.99B |
|
$94.00M |
|
$2.08B |
|
$2.08B |
|
$2.18B |
|
$2.18B |
|
$2.18B |
|
$2.18B |
|
$1.99B |
|
-- |
|
1.24B |
|
1.25B |
|
$1.76 |
|
$1.74 |
|
| Balance Sheet Financials | |
$19.89B |
|
$5.61B |
|
$39.14B |
|
$59.02B |
|
$11.81B |
|
-- |
|
|
Long-Term Liabilities |
$24.59B |
$36.41B |
|
-- |
|
$-2.67B |
|
$22.62B |
|
1.24B |
|
| Cash Flow Statement Financials | |
$10.02B |
|
$-4.79B |
|
$-7.75B |
|
$9.99B |
|
$7.56B |
|
$-2.43B |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|